Oncology: Liver

You have access
Safety and efficacy of holmium-166 radioembolization in hepatocellular carcinoma – the HEPAR Primary study
Margot Thea Maria Reinders, Karel J. van Erpecum, Maarten L. J. Smits, Arthur Johannes Anthonius Theodorus Braat, Joep de Bruijne, Rutger C.G. Bruijnen, Dave Sprengers, Robert A. de Man, Erik Vegt, Jan N.M. IJzermans, Adriaan Moelker and Marnix Lam

Journal of Nuclear Medicine May 19, 2022, jnumed.122.263823; DOI: https://doi.org/10.2967/jnumed.122.263823
You have access
SIR-Spheres activity measurements reveal systematic miscalibration
Stephen A Graves, Molly Martin, Ashok Tiwari, Michael J Merrick and John J Sunderland

Journal of Nuclear Medicine January 6, 2022, jnumed.121.262650; DOI: https://doi.org/10.2967/jnumed.121.262650
You have access
Radioembolization Dosimetry with Total-Body ⁹⁰Y PET
Gustavo Coelho Alves Costa, Benjamin A. Spencer, Negar Omidvari, Cameron Foster, Michael Rusnak, Heather Hunt, Denise T Caudle, Rex Pillai, Catherine Vu and Emilie Roncali

Journal of Nuclear Medicine November 18, 2021, jnumed.121.263145; DOI: https://doi.org/10.2967/jnumed.121.263145
You have access
Pre-treatment sTNFR1 and HGF levels predict toxicity and overall survival after ⁹⁰Y radioembolization: potential novel application of biomarkers for personalized management of hepatotoxicity
Matthew M. Cousins, Theresa P. Devasia, Christopher M. Maurino, Justin Mikell, Matthew J. Schipper, Ravi K. Kaza, Theodore S. Lawrence, Kyle C. Cuneo and Yuni K. Dewaraja

Journal of Nuclear Medicine September 9, 2021, jnumed.121.262447; DOI: https://doi.org/10.2967/jnumed.121.262447

Main menu

User menu

Search

Oncology: Liver